• NEWS
  • NEWS
  • NEWS
  • NEWS
  • NEWS
  • NEWS

The latest news on XGEN and its companies.

Follow us on LinkedIn

XGEN Venture, a leading venture capital firm specializing in life sciences investments, proudly announces the final closing of its XGEN...
Tes Pharma, a biotech company focused on delivering first-in-class therapeutics for high unmet medical needs in oncology, renal and metabolic...
PAGE Therapeutics is a Swiss preclinical-stage biotechnology company spun out of ETH Zurich, based on the groundbreaking science of Prof....
Genespire, a biotechnology company developing off-the-shelf gene therapies for pediatric patients affected by genetic diseases, today announced the closing of...
New financing for Protembis to accelerate ‘research and development’ programs, global ‘market access’ initiatives, and to complete the pivotal FDA...
XGEN Venture – a newly formed Venture Capital firm - announces its first fund, XGEN Venture Life Science Fund, with...
Protembis GmbH (Protembis) a privately-held emerging cardiovascular medical device company, announced today the enrollment of the first patient in the...
Protembis GmbH (Protembis), a privately-held emerging cardiovascular medical device company, announced today the completion of a € 30 million Series...
Basel-based biotech Nouscom has raised €67.5 million ($72.2 million) to bankroll its cancer vaccines as the eight-year-old company looks to...